Literature DB >> 2786666

Epidemiology of anxiety disorders in Florence.

C Faravelli1, B Guerrini Degl'Innocenti, L Giardinelli.   

Abstract

A structured interview designed to diagnose anxiety disorders according to DSM-III (plus infrequent panic attacks and generalized anxiety disorder using DSM-III-R criteria) was given to 1110 people registered with 6 general practitioners (GPs), whether they consulted the doctor or not. As each citizen in Italy has to be registered with a GP, the sample was representative of the population. The interviews were carried out by the GPs, who were also third- or fourth-year trainees in psychiatry. The lifetime prevalence and point prevalence were: 0.36% and 0.27% for agoraphobia; 0.90% and 0.72% for agoraphobia with panic; 1.35% and 0.27% for panic disorder; 0.63% and 0.45% for simple phobia; 0.49% and 45% for social phobia, 5.41% and 2.79% for generalized anxiety disorder; and 0.72% and 0.63% for obsessive-compulsive disorder. These figures are lower than those reported in other surveys; possible explanations may be the use of a hierarchical diagnostic model and the fact that diagnosticians were psychiatrists instead of lay interviewers as in most studies in the United States. On the whole, 62% of anxiety cases consult a GP, 50% consult a psychiatrist and 7% are hospitalized.

Entities:  

Mesh:

Year:  1989        PMID: 2786666     DOI: 10.1111/j.1600-0447.1989.tb10263.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  13 in total

1.  Epidemiology of somatoform disorders: a community survey in Florence.

Authors:  C Faravelli; S Salvatori; F Galassi; L Aiazzi; C Drei; P Cabras
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-01       Impact factor: 4.328

2.  The regional distribution of anxiety disorders: implications for the Global Burden of Disease Study, 2010.

Authors:  Amanda J Baxter; Theo Vos; Kate M Scott; Rosana E Norman; Abraham D Flaxman; Jed Blore; Harvey A Whiteford
Journal:  Int J Methods Psychiatr Res       Date:  2014-07-22       Impact factor: 4.035

3.  The European Study of the Epidemiology of Mental Disorders (ESEMeD/MHEDEA 2000) project: rationale and methods.

Authors:  J Alonso; M Ferrer; B Romera; G Vilagut; M Angermeyer; S Bernert; T S Brugha; N Taub; Z McColgen; G de Girolamo; G Polidori; F Mazzi; R De Graaf; W A M Vollebergh; M A Buist-Bowman; K Demyttenaere; I Gasquet; J M Haro; C Palacín; J Autonell; S J Katz; R C Kessler; V Kovess; J P Lépine; S Arbabzadeh-Bouchez; J Ormel; R Bruffaerts
Journal:  Int J Methods Psychiatr Res       Date:  2002       Impact factor: 4.035

4.  Understanding the relationships between health outcomes in generalized anxiety disorder clinical trials.

Authors:  Kathleen W Wyrwich; Neesha Harnam; Julie C Locklear; Henrik Svedsäter; Dennis A Revicki
Journal:  Qual Life Res       Date:  2010-08-31       Impact factor: 4.147

5.  The Zurich study. XX. Social phobia and agoraphobia.

Authors:  M Degonda; J Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

6.  The Zurich Study. XVIII. Obsessive-compulsive disorders and syndromes in the general population.

Authors:  M Degonda; M Wyss; J Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

7.  Community effects on mental health outcomes in subjects with and without panic attacks: results from a population-based study in san antonio, Texas.

Authors:  David A Katerndahl
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

Review 8.  Classification and epidemiology of social phobia.

Authors:  J P Lépine; J Lellouch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

9.  The epidemiology of anxiety disorders: a review.

Authors:  Patrick Martin
Journal:  Dialogues Clin Neurosci       Date:  2003-09       Impact factor: 5.986

10.  A nationwide population-based cohort study: will anxiety disorders increase subsequent cancer risk?

Authors:  Ji-An Liang; Li-Min Sun; Kuan-Pin Su; Shih-Ni Chang; Fung-Chang Sung; Chih-Hsin Muo; Chia-Hung Kao
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.